Park Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Park Therapeutics General Information

Description

Manufacturer of drugs intended to address acute and chronic pain without the risks associated with traditional opioids. The company has products for nociceptive and neuropathic pain while maintaining a highly differentiated safety profile.

Contact Information

Website
www.parktherapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 45 South Park Place
  • Suite 105
  • Morristown, NJ 07960
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Tris Pharma
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 45 South Park Place
  • Suite 105
  • Morristown, NJ 07960
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Park Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Park Therapeutics‘s full profile, request access.

Request a free trial

Park Therapeutics Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Park Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024173714-A1 Regimens and compositions useful for alleviating pain Inactive 15-Feb-2023
WO-2024129782-A1 Regimens and compositions useful for alleviating pain Inactive 12-Dec-2022
CA-3032823-A1 Room temperature stable oral calcitonin formulation Pending 05-Aug-2016
US-20250057771-A1 Room temperature stable oral calcitonin formulation Pending 05-Aug-2016
CA-3015420-A1 Titration of cebranopadol Active 29-Feb-2016 A61K31/407
To view Park Therapeutics’s complete patent history, request access »

Park Therapeutics FAQs

  • When was Park Therapeutics founded?

    Park Therapeutics was founded in 2020.

  • Where is Park Therapeutics headquartered?

    Park Therapeutics is headquartered in Morristown, NJ.

  • What industry is Park Therapeutics in?

    Park Therapeutics’s primary industry is Drug Discovery.

  • Is Park Therapeutics a private or public company?

    Park Therapeutics is a Private company.

  • What is Park Therapeutics’s current revenue?

    The current revenue for Park Therapeutics is .

  • When was Park Therapeutics acquired?

    Park Therapeutics was acquired on 29-Apr-2021.

  • Who acquired Park Therapeutics?

    Park Therapeutics was acquired by Tris Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process